Metagenomi, Inc. (MGX) - Dilution Analysis

10-Q filing | 37.6M shares outstanding

10-Q filing | 37.3M shares outstanding

10-Q filing | 37.2M shares outstanding

10-Q filing | 37.0M shares outstanding

S-3 filing: The filing is an S-3 shelf registration statement for the potential offering of up to $250,000,000 in aggregate principal amount of common stock, preferred stock, debt securities, warrants and/or units, and also details an at-the-market offering of common stock up to $75,000,000 through Jefferies LLC.

10-K filing | 37.4M shares outstanding

10-Q filing | 36.8M shares outstanding

10-Q filing | 36.6M shares outstanding

10-Q filing | 37.5M shares outstanding

S-1/A filing: This S-1/A filing is for an initial public offering of common stock, with 6,250,000 shares being offered at an initial public offering price of $16.00 per share. The underwriters have an option to purchase up to 937,500 additional shares.

S-1/A filing: This S-1/A filing from Metagenomi details an offering of 6,250,000 shares of common stock, with underwriters having an option to purchase an additional 937,500 shares, and provides information on the company's financials, proposed Nasdaq listing, and use of proceeds.

S-1/A filing: S-1/A filing for an offering of common stock.

S-1 filing: This is an S-1 filing for an initial public offering of common stock. The company has applied to list on the Nasdaq Global Select Market under the symbol 'MGX'.